![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 20, 2016 3:26:51 PM
------------------------------------------------------------------
geocappy1 Wednesday, 08/31/16 10:53:17 AM
Re: CloakedProtector post# 271253
Post # of 272872
I will vote no. If I was sure they were only using authorization for extending nasdaq for 6 months and seeing what happened with other events then maybe. But of course they didn't give us that and I don't trust them
To me, going of the Nasdaq is not the death sentence you lay out and if they have what you say or they say then it won't matter. There is other funding out there (which they shouldn't need much if they deliver on Avids). It might be more expensive but not as detrimental as increasing PPS through RS and allowing shorts more room to bury us.
IMO we are idiots if we give the same BOD with the same lack of communication another run without exacting a price for their miscalculations. Paul Lytle at $700k is joke. The same BOD is also a joke. We have no other leverage but to try to stop the RS (sure no hope with folks like yourself accepting any and everything they do) without some type of fight.
I can only hope the Darts and limited institution support is against it. There should be some price to pay for the mistakes they have made(insistence on going it alone).
------------------------------------------------------------------
Wednesday, 09/07/16 10:01:56 AM
Re: bidrite post# 271700
Post #
271725 ( Threes )
of 272873 Go
I received my proxy today from TD.
Withheld BOD,
FOR E&Y,
AGAISNT reverse split, that was no brainier.
It's like going into surgery and the doctor asking with or without anesthesia and should I wipe off the scalable.
Unless you love pain and want to die it's pretty easy decision.
RS will kill shareholders 95% of the time stocks that RS return to the pre split SP.
So end of the day 100,000 shares at .40 will be 14,500 shares at .40. What a great deal that will be for shareholders.
We have 60 million in the bank . USE IT WISELY.
Against compensation, they should be cutting there salaries or taking zero dollars until they cut cost and turn a profit via AVID.
Get Adaptive Portfolio and We'll Waive our Advisory Fee until 2017
------------------------------------------------------------------
biopharm Member Level Sunday, 09/11/16 08:56:55 AM
Re: BioBS2012 post# 272265
Post # of 272874
BioBS2012, I agree and I think we should take it further... IF Peregrine makes a statement like this and foresees no need to raise funds for the next 12 months..... (playing devils advocate here..) that means there is certainly no emergency to get this stock over $1 VIA a RS so there should definately be an extension filed
I think it will happen naturally with pending PR's / Wolchok lab / Sunrise study data / Avid revenue..etc..etc
Quote:
"Although it is difficult to predict all of our future liquidity requirements, we believe that our cash and cash equivalents as of July 31, 2016 combined with
the additional proceeds raised subsequent to July 31, 2016 and through September 8, 2016, and the projected cash receipts from manufacturing services will be
sufficient to fund our operations through at least the next twelve months, which estimate assumes we raise no additional capital from the capital markets or other
potential sources."
As for the 1:7 even being brought up, I still have to say there is a party that owns 50%+ of the stock even though they may not be legally considered a group (but maybe that will change...) and would a group like this want to make a move on Peregrine or be willing to simply risk their shares being reduced .... => leaving the door wide open to give control to someone else that would be willing to come up with better terms for a M/A deal
------------------------------------------------------------------
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM